The Weekly Roundup: March 2-6

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Derm Dash at Winter Clinical Miami 2026 with James Del Rosso, DO

James Del Rosso, DO, shares rapid-fire insights on mentorship, HS advances, contact dermatitis triggers, and teen skin care marketing concerns.

Balancing Operational Systems with Professional Identity at Winter Clinical Miami

Terrence Keaney, MD, and Dawn Merritt, DO, discuss AI workflows and smart practice systems—plus how a dermatology niche drives referrals and growth.

Thinking Outside the Box: Diego Ruiz Dasilva, MD, FAAD, on the Power of Case-Based Combo Therapy

Ruiz Dasilva emphasized case-based strategies for managing complex inflammatory dermatoses, highlighted chronic pruritus as an urgent unmet need, and called for more standardized designs for atopic dermatitis trials.

From Photodamage to Prevention: Brian Berman, MD, PhD, on Evolving AK Treatment Strategies

Brian Berman, MD, PhD, explains actinic keratosis-to-SCC risk and newer PDT/field therapies that improve clearance with less pain.

Investigators Present Design of Phase 3 CLEAR CSCC Trial of Cemiplimab for Early-Stage CSCC

CLEAR CSCC is evaluating whether low-dose intralesional cemiplimab is noninferior to primary surgery, potentially offering a tissue-sparing alternative to standard surgical management.

Dermoscopy Enhances Early Detection of ICI-Induced Skin Reactions

Skin adverse events linked to immunotherapy may correlate with improved tumor response and survival, underlining their clinical significance.

Novel CD200R Agonist ARQ-234 Advances to First-in-Human Study in AD

The double-blind, randomized, placebo-controlled ARQ-234-131 study will assess safety, tolerability, pharmacokinetics, and early signs of clinical activity.

FDA Accepts and Grants Priority Review of NDA for Brepocitinib in Dermatomyositis

Priovant Therapeutics’ brepocitinib has been assigned a PDUFA date of the third quarter of 2026.

Kyowa Kirin Ends Late-Stage Rocatinlimab OX40 Development

Rocatinlimab had met primary end points in large phase 3 trials and was previously expected to move toward regulatory submission in 2026.

FAQtual Insights: Systemic Risk and Targeted Therapy in GPP

A panel discussion highlights the diagnostic variability, systemic risk, and evolving treatment landscape of GPP.

Beyond Voluntourism: An Integrated Ophthalmology-Dermatology Mission to Nepal

In December 2025, Dooley Intermed International, Operation Restore Sight, and Reiyukai Eiko Masunaga Eye Hospital (REMEH) in Nepal joined forces with dermatology specialists from Scripps Clinic in a pioneering multidisciplinary mission that exemplified the principles of sustainable medical volunteerism.

Dermatology Times Conferences & Meetings Calendar: March 2026

Explore top dermatology conferences and meetings in March 2026 and let us know which ones you'll be attending!

Clothing, Careers, and Climate: HS Influence on Choices

A qualitative study found that hidradenitis suppurativa significantly influences patients’ daily decisions, emotional health, relationships, and financial stability.

Mapping the Cytokine Landscape: A Multidisciplinary Approach to Immune-Mediated Disease

Nicholas Brownstone, MD, and other experts spotlighted cytokine hubs at Winter Clinical Miami 2026, linking CSU and PsO/PsA to smarter targeted treatment choices.

Andrew Baker, PA-C, on the Evolution of NP and PA Integration

Baker explains why competency-based autonomy and structured collaboration are essential in high-acuity medical dermatology.

Treatment Considerations for Type 2 Inflammation

During the first half of the Horizons in Advanced Practice breakout sessions, Omar Noor, MD, FAAD, presented patient cases related to type 2 inflammation and available treatment options.

SLIDESHOW: 15 Tips in 15 Minutes at WCM 2026

Winter Clinical Miami experts shared professional development tips and clinical pearls during the meeting's classic "15 Tips in 15 Minutes" session.

Top-Line Results Show Day 57 Tumor Clearance With Investigational BCC Patch

Clearance rates increased between days 29 and 57, with the highest activity observed in the 200-μg treatment group.

Society for Pediatric Dermatology and Dermatology Times Launch Strategic Podcast Collaboration to Elevate Pediatric Dermatology

The reimagined Don’t Be Rash podcast positions industry leaders at the center of pediatric skin conversations.

Why Clinical Context is Key for Rare Cases and Diverse Skin Types

At Winter Clinical Miami 2026, Andrew F. Alexis, MD, MPH, shares skin-of-color therapy pearls as Clay Cockerell, MD, spotlights must-biopsy mimickers.

Topical JAK Inhibition for Chronic Hand Eczema

Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, highlighted that CHE is often mischaracterized and frequently involves overlapping subtypes.

FAQtual Insights: The HS Questions We Don’t Ask Out Loud

This FAQ answers top questions of HS therapy: when to escalate to biologics, add surgery, measure success, and support mental health.

Full Conference Recap: Winter Clinical Miami 2026

Catch up on coverage from this year's Winter Clinical Miami meeting.

Plugged In: How Dermatology Podcasts Are Reshaping Patient Education and Physician Connectivity

The on-demand format of podcasts allows learners at all levels to engage with expert insights conveniently.

SLIDESHOW: Quick Takeaways From the PDPA's 2025 Compensation Survey

Explore PDPA’s 2025 compensation survey, revealing dermatology PA salary trends, workload patterns, benefits insights, and job satisfaction across the state of Pennsylvania.

Delgocitinib Reduces Work and Activity Burden in CHE

At week 16, 73.3% of patients receiving delgocitinib achieved a clinically meaningful (≥4-point) DLQI improvement versus 47.8% with vehicle.

The Cutaneous Connection: Skin Changes, Hormones, and the Menopause Conversation in Aesthetics

In the latest Cutaneous Connection podcast episode, Doris Day, MD, FAAD, offers practical guidance for clinicians looking to incorporate discussions of hormonal health into aesthetic practice with menopausal patients.

Celebrating Women in Dermatology: The Enduring Influence of Marianne O’Donoghue, MD

O’Donoghue, a respected dermatologist and educator, left a lasting impact through her leadership, scholarship, and dedication to family and faith.